SlideShare a Scribd company logo
PH2.4
DEMONSTRATE THE CORRECT METHOD
OF CALCULATION OF DRUG DOSAGE IN
PATIENTS INCLUDING THOSE USED IN
SPECIAL SITUATIONS
Dr. Mani Bharti
S.R. Pharmacology
North DMC,Medical College,Delhi
Competency: PH 2.4
• Demonstrate the correct method of calculation of drug
dosage in patients including those used in special
situations
Domain
S
Level
S H
Core
(Y)
Suggested
Teaching
Learning method
DOAP sessions
Suggested
Assessment
method
Skills
assessment
Vertical
Integration
Pediatrics,
General
Medicine
Learning Objectives
At the end of the teaching learning session, the M.B.B.S Phase II
student shall be able to
• Know the general methods for drug dose calculation.
• Calculate the number of tablets/ quantities of solution or
drip rate for a given condition
• Calculate the doses for various drugs in pediatric
population using appropriate formulae.
• Calculate the doses for various drugs in special situations
(renal/hepatic/heart diseases/obesity) using appropriate
formulae.
• Calculate the loading & maintenance doses.
GENERAL METHODS FOR DRUG
CALCULATION
1. BASIC FORMULA
2. RATIO& PROPORTION
3. FRACTIONAL EQUATION
4. BODY WEIGHT
5. BODY SURFACE AREA
1. Basic Formula
• A=D/H X V
• D-desired dose (drug dose ordered by health care
provider)
• H- on-hand (stock on hand/on label of container)
• V- vehicle ( Q- quantity/drug form in which drug comes)
• A- Amount calculated to be given to patient.
Examples:
• Avandia 2mg OD. How much tablet will you give?
A=D/HXV
• Solution: 2mg/4 x 1 tablet 4mg = .5 tablet
Example
• Paracetamol 500mg. Q 4 hour Round the Clock (RTC)
p.o. The stock on hand is 250mg/5ml in 60ml bottle. How
many ml should be administered?
• D-500 mg, V- 5 ml,H-250mg
• A=D/H X V
A=500/250 X 5= 10 ml
2. Ratio and Proportion
• H : V = D : X
• Where: H = drug on hand (available)
• V = vehicle/drug form (capsule/tablet/liquid)
• D = desired dose (as ordered)
• x = unknown amount to give
Example
• Order: Cefdinir (3rd gen cephalosporin) 100 mg PO q.i.d
*How many mL should the patient receive?
• H : V = D : X
• 250:5=100:X
• X=DV/H
• X=100X5/250
• X=2 ML
Fractional Equation
• • Same as R & P except it is written as a fraction.
• H/V = D/X
• Example
• Order:Ciprofloxacin 250 mg PO q12h*how many tablets
should the client receive?
• H/V = D/X
• 750/1=250/X
• 1/3 Tab
4. Body Weight (BW)
• Allows individualization of the drug dose
• Involves 3 steps:
1. Convert pounds to kg – 1 Kg = 2.2 lbs
2. 2. Determine drug dose per BW – Drug dose x body
weight = patients dose per day
3. 3. Follow basic formula, R & P
Example
• Order: Fluorouracil (5-FU), 12 mg/kg/day IV, not to exceed
800 mg/day. The adult weighs 132 lb.
• 1. Convert pounds to Kg :
• 132/2.2 = 60kg
• 2. mg x kg = patient’s dose: 12 x 60 = 720mg/day
• Answer: fluorouracil 720 mg/day
5. Body Surface Area (BSA)
Most accurate to calculate drug dose for:
– Infants
– Children
– Older adults
– patients who are on antineoplastic agents
– low body weight
BSA is expressed as square meters (m2).
It can be determined using: -
Equations (e.g., Mosteller Method, Du Bois Method) –
Nomograms
- An average-sized adult has a BSA of 1.73 m2
Mosteller Equations:
Example
nomogram
• A nomogram has three columns:
• - Height (expressed in centimeters and in inches)
• - Body surface area (expressed in square meters)
• - Weight (expressed in kilograms and in pounds)
• - To use a nomogram, the height and weight of a patient
are found on the nomogram and then a straight line is
drawn connecting the two values.
• - The BSA for that patient is found where the line
intersects the BSA column.
Example
• Order:Cyclophosphamide (Cytoxan) 100 mg/m2/day,
• IV; available dosage is 200mg; patient’s height is 70
inches, weight is 160 lbs.
• 1. 70 inches and 160 lbs intersect the nomogram scale at
1.97 m2 (BSA).
• 2. 100 mg x 1.97 = 197mgAnswer:Administer
cyclophosphamide 197 mg/day
Nomogram for estimation of BSA
Estimation of BSA
IV Drip Rate Calculation:
Drop factor of tubing:
• Macrodrip = 10, 15, or 20 gtt/mL
• Microdrip = 60 gtt/mL
• The drop factor of the tubing is found on the tubing box.
For calculations, it must be stated in the problem.
Example
A patient is to receive 1 L of Hartmann’s solution over the
next 12 hours. What is the rate of infusion in drops per
minute (dpm), if the drop factor is 60 drops per mL .
Solution: Volume = 1 000 mL, since 1 L = 1 000 mL.
Time = 12 hours.
Drop Factor = 60 drops per mL.
Substituting these values into the drip rate formula gives:
Drip Rate (dpm) = 1 000ml/ 12 hr × 60 drops/ml/60 min/ h
= 83.833 ≈ 84 drops/minutes .
Drug dosing in special populations
• A special population are persons displaying one or more
of the following characteristics:
• a. prone to under or over responding to usual dosing
regimens
• b. least able to tolerate, recognize, or communicate drug
effects
• c. accidentally frequently mis‐dose
Patient conditions that may altered the
dosing of most drugs
• • Renal or hepatic disease,.
• • Dialysis procedures
• • Heart failure
• • Obesity
• • Age.
Renal Disease
Two important equatation are there for calculation of drug
dose in renal disease patients
Cockcroft-gault
MDRD(eGFR)
• The most common method of estimating glomerular
filtration for the purpose of drug dosing is to measure
/estimate Creatinine Clearance CrCl(ml/min)
MDRD equation
eGFR is estimated GFR calculated by the abbreviated MDRD equation :
186 x (Creatinine/88.4)-1.154 x (Age)-0.203 x (0.742 if female) x (1.210 if black).
Modifying Doses for patients with renal
impairment
• It is possible to decrease the drug dose
and retain the usual dosage interval, or
• Retain the usual dose and increase the
dosage interval, or
• Both decrease the dosage and prolong
the dosage interval
• The choice was made depend on the
route of drug administration, the dosage
forms available
St
Stageg GFR* Description
1 90+
Normal kidney function but urine findings or structural
abnormalities or genetic trait point to kidney disease
2 60-89
Mildly reduced kidney function, and other findings (as for
stage 1) point to kidney disease
3A
3B
45-59
30-44
Moderately reduced kidney function
4 15-29 Severely reduced kidney function
5
<15 or on
dialysis Very severe, or end-stage kidney failure
For drugs with narrow therapeutic index
• Measured or estimated CrCl may be used to
estimate pharmacokinetic parameters for a patient
based on prior studies conducted in other patients
with renal dysfunction
• Estimated pharmacokinetic parameters are then
used in pharmacokinetic dosing equation to
compute initial dose
Hepatic Disorders
• Most lipid soluble drugs are metabolized to some
degree by the liver
Two major types of liver disease
1. Hepatitis ‐ Acute hepatitis: mild, transient
decreases in drug metabolism required no or minor
changes in drug dosing ‐ Chronic hepatitis:
irreversible hepatocytes damage required drug
dosage changes. Patients with long term
hepatocytes damage can progress to hepatic
cirrhosis
2. Cirrhosis; a permanent lost of functional
hepatocytes. Drug dosage schedules usually need
to be modified
Heart Failure
• Is accompanied by a decrease in cardiac output
results in lower liver and renal blood flow
• Decreased drug bioavailability has been
reported, due to collection of edema fluid in the GI
tract difficult absorption and decreased blood flow
to GI tract
Obesity
• Estimating the optimal dose for obese patients
is difficult and, in many cases, ill defined.
• Basing maintenance doses on total body
weight is unlikely to result in a comparable
drug response across different body sizes and
generally increases the risk of adverse events.
Individualised
• dosing based on the patient’s lean body
weight is recommended, with accompanying
therapeutic drug monitoring and monitoring of
the patient’s clinical response
• .
Body size descriptors commonly used in
drug dosing
Name Formula
Total body weight (kg) –
Ideal body weight (kg)
13
45.4 + 0.89 x (height (cm) – 152.4) +
(4.5 if male)
Adjusted body weight (kg) Correction factor* x (TBW – IBW) +
IBW
Lean body weight (kg)
males 9270 x TBW (kg)6680+216 x BMI (kg/
m2)
Females 9270 x TBW (kg)6680+244 x BMI (kg/
m2)
Age
Children are not small adults but rather distinct
individuals who have different absorption,
distribution, metabolism, and excretion rates of
medications than adults.
Pediatric considerations
• Fried’s rule –
• applies to the child younger than 1 year of age.
• Infant dose=
• infant age (months) X adult average dose/ 150
Pediatric considerations
• Young’s Rule-
• applies to children 1-12 yr.
Clark’s Rule
• One of the most popular methods for determining
medication dosages for children.
• Based upon a child’s body weight and the assumption that
the average normal adult weighs 150 pounds.
• Ratio proportions are used in this method.
• Clark’s rule should be used if no other formula is
specified.
Loading doses
Loading doses are useful for drugs that are eliminated from the
body relatively slowly
• Such drugs need only a low maintenance dose in order to
keep the
amount of the drug in the body at the target level
• Without loading, it would take longer for the amount of the
drug to
reach target level
• Loading doses typically are adjusted based on Vd and are
not adjusted
for renal failure
•If extracellular volume depletion is present, Vd may be
reduced and
reductions in loading dose should occur
Three variables are used to calculate the loading dose:
• Cp = desired peak concentration of drug
• Vd = volume of distribution of drug in body
• F = bioavailability
•The required loading dose may then be calculated as:
Loading dose = Cp x Vd x Ideal body weight/F
•For an intravenously administered drug, the bioavailability F
will equal 1, since the drug is directly introduced to the
bloodstream.
If the patient requires an oral dose, bioavailability will be less
than 1 (depending upon absorption, first-pass metabolism,
etc.),
requiring a larger loading dose
Drug Dosing–Maintenance Dose
• Maintenance doses ensure steady-state blood
concentrations and lessen the likelihood of sub-therapeutic
regimens or overdoses
•In the absence of a loading dose, maintenance doses will
achieve 90% of their steady-state level in 3–4½ lives
•Two options for ESRD
• Reduce the dose
• Lengthen the interval between doses (more useful for a
drug with a wide therapeutic range and long half-life)
• Maintenance dose can be calculated the same way as
loading dose
Conversions:
• 1 liter (L) = 1000 ml (milliters)
• 1 gram (g) = 1000 mgs (milligrams)
• 1 mg (milligrams) = 1000 mcgs (micrograms)
• 1 gram (g) = 15 grain (gr)
• 1 grain (gr) = 60 mg (milligrams)
• 1 dram (dr) =4 ml (milliters)
• 1 ounce (oz) = 30 ml (milliters)
• 1 tsp (teaspoon) = 5 ml (milliters)
• 1 tbs (tablespoon) = 15 ml (milliters)
• 1 kg (kilogram) = 2.2 lbs (pounds)
• 1 inch = 2.54 cm (centimeters)
• 16 ounces (ozs) = 1 lb (pound)
• 1 cup = 8 ounces (ozs)
1 ml (milliter) = 15 minims
• 1 tsp (teaspoon) = 5 ml (milliters)
• 1 tbs (tablespoon) = 15 ml (milliters)
• 1 drop (gtt) = 15 minims
Q. The normal adult doses of medication
is 150 mg you have a child that weighs
30 kg and is 1.2 meter in height. How
much medication will you give to the
child?
Answer
• Calculate BSA= 30kg x120cm/3600 =1 , now child
dosage= BSA x ADULT DOSE / 1.7M2 = 88.24mg
Q. A pediatric patient is to receive
Atropine 0.02 mg/kg,the patient weight
is 10 kg,what is the Desired Dose?
• Desired Dose = .02mg/kg*10kg=.2mg
Answer
Q. Calculate the dose of Amoxicillin for 8 yr old girl using
young’s formula ,when the adult dose of capsule
Amoxicillin is 250 mg TDS ?
• Youngs Formula = (Age/Age+12 )*Adult Dose so
(8/8+12)*250 = 100mg
Answer
Q. Calculate the dose of Amoxicillin for 8 yr old girl using
young’s formula ,when the adult dose of capsule
Amoxicillin is 250 mg TDS ?
• Youngs Formula = (Age/Age+12 )*Adult Dose so
(8/8+12)*250 = 100mg
Answer
Q. Find out the dose of cephalexin
using Dilling’s formula for a 2 yr
old child when the adult dose is
500 mg TDS?
• Dillings formula ={( Age / 20) *Adult Dose } , So 2/20 *500
= 50 mg
Answer
•Find out the dose of a drug X for a
3 yr old child by Dilling formula as
well as young formula when adult
dose of that drug is 650 mg TDS.
• Dilling formula = Age/20 *Adult dose , So here Dose =
4/20*500mg=100mg
Answer
• Calculate the daily dose of Amikacin for 75 years old
female obese patient weight 90 kg having S. creatinine –
2.5 mg/dl suffering from renal parenchyma disease.
• Creatinine clearance in renal insufficiency = ( 140 - Age ) *
Weight ( kg ) multipy 0.85 ( If females) /72 * S.
Creatinine ( mg / ml )
• 140-75 *90*0.85*100/72*2.5 =2.763gm.
•Thank you

More Related Content

What's hot

Pharmacotherapeutics
PharmacotherapeuticsPharmacotherapeutics
Pharmacotherapeutics
atharshamim
 
Dosage regimen
Dosage regimenDosage regimen
General prescribing guidelines_for_pregnancy_and_breast_feeding
General prescribing guidelines_for_pregnancy_and_breast_feedingGeneral prescribing guidelines_for_pregnancy_and_breast_feeding
General prescribing guidelines_for_pregnancy_and_breast_feeding
Venkata subbareddy Bareddy
 
Critical evaluation of biomedical literature - clinical pharmacy
Critical evaluation of biomedical literature - clinical pharmacyCritical evaluation of biomedical literature - clinical pharmacy
Critical evaluation of biomedical literature - clinical pharmacy
ShaistaSumayya
 
Dose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failureDose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failure
Pallavi Kurra
 
Calculation of drug dosage (Posology )
Calculation of drug dosage (Posology )Calculation of drug dosage (Posology )
Calculation of drug dosage (Posology )
Amit Kumar
 
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
RxVichuZ
 
INTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACYINTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACY
Venkata subbareddy Bareddy
 
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptxGENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
kavitharaninachiya
 
Antiasthmatic drugs
Antiasthmatic drugsAntiasthmatic drugs
Antiasthmatic drugsDr UAK
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
Prafull Jain
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
Jitendra Chaturvedi
 
Rational drug use
Rational  drug  useRational  drug  use
Rational drug use
Likhita Kolli
 
1 drugs acting on cardiovascular system
1 drugs acting on cardiovascular system1 drugs acting on cardiovascular system
1 drugs acting on cardiovascular systemGyanendra Raj Joshi
 
Atorvastatin
AtorvastatinAtorvastatin
Atorvastatin
Teena Patra
 
Antidotes and its clinical application
Antidotes and its clinical applicationAntidotes and its clinical application
Antidotes and its clinical application
kritijain857168
 
General prescribing guidelines_of_geriartric_patients
General prescribing guidelines_of_geriartric_patientsGeneral prescribing guidelines_of_geriartric_patients
General prescribing guidelines_of_geriartric_patients
Venkata subbareddy Bareddy
 

What's hot (20)

Pharmacotherapeutics
PharmacotherapeuticsPharmacotherapeutics
Pharmacotherapeutics
 
Dosage regimen
Dosage regimenDosage regimen
Dosage regimen
 
General prescribing guidelines_for_pregnancy_and_breast_feeding
General prescribing guidelines_for_pregnancy_and_breast_feedingGeneral prescribing guidelines_for_pregnancy_and_breast_feeding
General prescribing guidelines_for_pregnancy_and_breast_feeding
 
Critical evaluation of biomedical literature - clinical pharmacy
Critical evaluation of biomedical literature - clinical pharmacyCritical evaluation of biomedical literature - clinical pharmacy
Critical evaluation of biomedical literature - clinical pharmacy
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Dose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failureDose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failure
 
Calculation of drug dosage (Posology )
Calculation of drug dosage (Posology )Calculation of drug dosage (Posology )
Calculation of drug dosage (Posology )
 
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
 
INTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACYINTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACY
 
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptxGENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
 
Antiasthmatic drugs
Antiasthmatic drugsAntiasthmatic drugs
Antiasthmatic drugs
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
 
Calculation of Doses
Calculation of DosesCalculation of Doses
Calculation of Doses
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
 
Rational drug use
Rational  drug  useRational  drug  use
Rational drug use
 
Pediatric Medication
Pediatric MedicationPediatric Medication
Pediatric Medication
 
1 drugs acting on cardiovascular system
1 drugs acting on cardiovascular system1 drugs acting on cardiovascular system
1 drugs acting on cardiovascular system
 
Atorvastatin
AtorvastatinAtorvastatin
Atorvastatin
 
Antidotes and its clinical application
Antidotes and its clinical applicationAntidotes and its clinical application
Antidotes and its clinical application
 
General prescribing guidelines_of_geriartric_patients
General prescribing guidelines_of_geriartric_patientsGeneral prescribing guidelines_of_geriartric_patients
General prescribing guidelines_of_geriartric_patients
 

Similar to drug dose calculation in special populatation

Individualisation and optimization of drug dosing regimen
Individualisation and optimization of drug dosing regimenIndividualisation and optimization of drug dosing regimen
Individualisation and optimization of drug dosing regimen
Jyoti Nautiyal
 
Pediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulasPediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulas
NEHA MALIK
 
Dosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptxDosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptx
SaishDalvi
 
Drug dosing
Drug dosingDrug dosing
Drug dosing
Doha Rasheedy
 
App p'kinetic 112070804003
App p'kinetic 112070804003App p'kinetic 112070804003
App p'kinetic 112070804003
Patel Parth
 
App p'kinetic 112070804003
App p'kinetic 112070804003App p'kinetic 112070804003
App p'kinetic 112070804003Patel Parth
 
PEDIATRIC DRUG CALCULATION.pptx
PEDIATRIC DRUG CALCULATION.pptxPEDIATRIC DRUG CALCULATION.pptx
PEDIATRIC DRUG CALCULATION.pptx
JamesTuckolon
 
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease. Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Kevin John
 
App p'kinetic 112070804003
App p'kinetic 112070804003App p'kinetic 112070804003
App p'kinetic 112070804003Patel Parth
 
Calculations of Doses
Calculations of DosesCalculations of Doses
Calculations of Doses
Areej Abu Hanieh
 
3. Clinical Phk-Dosing in special Population & TDM.pptx
3. Clinical Phk-Dosing in special Population & TDM.pptx3. Clinical Phk-Dosing in special Population & TDM.pptx
3. Clinical Phk-Dosing in special Population & TDM.pptx
jiregna5
 
Drug dosing in elderly, infant and obese patient slide share
Drug dosing in elderly, infant and obese patient slide shareDrug dosing in elderly, infant and obese patient slide share
Drug dosing in elderly, infant and obese patient slide share
javvadhasan
 
Clinical pharmackokinetics
Clinical pharmackokineticsClinical pharmackokinetics
Clinical pharmackokinetics
Dr Sajeena Jose
 
Pediatrics hypertension
Pediatrics hypertensionPediatrics hypertension
Pediatrics hypertension
BEZAWITBEWKETEU
 
Pharmacokinetics & BA - Part-2.pdf
Pharmacokinetics & BA - Part-2.pdfPharmacokinetics & BA - Part-2.pdf
Pharmacokinetics & BA - Part-2.pdf
SARADPAWAR1
 
Pharmacokinetics & BA - Part-2.pdf
Pharmacokinetics & BA - Part-2.pdfPharmacokinetics & BA - Part-2.pdf
Pharmacokinetics & BA - Part-2.pdf
SARADPAWAR1
 
Diagnosis and management of hypertension and hypertensive emergency
Diagnosis and management of hypertension and hypertensive emergencyDiagnosis and management of hypertension and hypertensive emergency
Diagnosis and management of hypertension and hypertensive emergency
Sheela Aglecha
 
5-6-(TPN).ppt
5-6-(TPN).ppt5-6-(TPN).ppt
5-6-(TPN).ppt
RatanYadav16
 
How to improve Peritoneal dialysis adequacy
How to improve Peritoneal dialysis adequacyHow to improve Peritoneal dialysis adequacy
How to improve Peritoneal dialysis adequacy
Ahmed Mostafa Taha Borham
 
NOMOGRAMS AND TABULATIONS IN DESIGNING DOSAGE REGIMEN.pptx
NOMOGRAMS AND TABULATIONS IN   DESIGNING DOSAGE REGIMEN.pptxNOMOGRAMS AND TABULATIONS IN   DESIGNING DOSAGE REGIMEN.pptx
NOMOGRAMS AND TABULATIONS IN DESIGNING DOSAGE REGIMEN.pptx
Firdous Ansari
 

Similar to drug dose calculation in special populatation (20)

Individualisation and optimization of drug dosing regimen
Individualisation and optimization of drug dosing regimenIndividualisation and optimization of drug dosing regimen
Individualisation and optimization of drug dosing regimen
 
Pediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulasPediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulas
 
Dosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptxDosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptx
 
Drug dosing
Drug dosingDrug dosing
Drug dosing
 
App p'kinetic 112070804003
App p'kinetic 112070804003App p'kinetic 112070804003
App p'kinetic 112070804003
 
App p'kinetic 112070804003
App p'kinetic 112070804003App p'kinetic 112070804003
App p'kinetic 112070804003
 
PEDIATRIC DRUG CALCULATION.pptx
PEDIATRIC DRUG CALCULATION.pptxPEDIATRIC DRUG CALCULATION.pptx
PEDIATRIC DRUG CALCULATION.pptx
 
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease. Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
 
App p'kinetic 112070804003
App p'kinetic 112070804003App p'kinetic 112070804003
App p'kinetic 112070804003
 
Calculations of Doses
Calculations of DosesCalculations of Doses
Calculations of Doses
 
3. Clinical Phk-Dosing in special Population & TDM.pptx
3. Clinical Phk-Dosing in special Population & TDM.pptx3. Clinical Phk-Dosing in special Population & TDM.pptx
3. Clinical Phk-Dosing in special Population & TDM.pptx
 
Drug dosing in elderly, infant and obese patient slide share
Drug dosing in elderly, infant and obese patient slide shareDrug dosing in elderly, infant and obese patient slide share
Drug dosing in elderly, infant and obese patient slide share
 
Clinical pharmackokinetics
Clinical pharmackokineticsClinical pharmackokinetics
Clinical pharmackokinetics
 
Pediatrics hypertension
Pediatrics hypertensionPediatrics hypertension
Pediatrics hypertension
 
Pharmacokinetics & BA - Part-2.pdf
Pharmacokinetics & BA - Part-2.pdfPharmacokinetics & BA - Part-2.pdf
Pharmacokinetics & BA - Part-2.pdf
 
Pharmacokinetics & BA - Part-2.pdf
Pharmacokinetics & BA - Part-2.pdfPharmacokinetics & BA - Part-2.pdf
Pharmacokinetics & BA - Part-2.pdf
 
Diagnosis and management of hypertension and hypertensive emergency
Diagnosis and management of hypertension and hypertensive emergencyDiagnosis and management of hypertension and hypertensive emergency
Diagnosis and management of hypertension and hypertensive emergency
 
5-6-(TPN).ppt
5-6-(TPN).ppt5-6-(TPN).ppt
5-6-(TPN).ppt
 
How to improve Peritoneal dialysis adequacy
How to improve Peritoneal dialysis adequacyHow to improve Peritoneal dialysis adequacy
How to improve Peritoneal dialysis adequacy
 
NOMOGRAMS AND TABULATIONS IN DESIGNING DOSAGE REGIMEN.pptx
NOMOGRAMS AND TABULATIONS IN   DESIGNING DOSAGE REGIMEN.pptxNOMOGRAMS AND TABULATIONS IN   DESIGNING DOSAGE REGIMEN.pptx
NOMOGRAMS AND TABULATIONS IN DESIGNING DOSAGE REGIMEN.pptx
 

Recently uploaded

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 

Recently uploaded (20)

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 

drug dose calculation in special populatation

  • 1. PH2.4 DEMONSTRATE THE CORRECT METHOD OF CALCULATION OF DRUG DOSAGE IN PATIENTS INCLUDING THOSE USED IN SPECIAL SITUATIONS Dr. Mani Bharti S.R. Pharmacology North DMC,Medical College,Delhi
  • 2. Competency: PH 2.4 • Demonstrate the correct method of calculation of drug dosage in patients including those used in special situations Domain S Level S H Core (Y) Suggested Teaching Learning method DOAP sessions Suggested Assessment method Skills assessment Vertical Integration Pediatrics, General Medicine
  • 3. Learning Objectives At the end of the teaching learning session, the M.B.B.S Phase II student shall be able to • Know the general methods for drug dose calculation. • Calculate the number of tablets/ quantities of solution or drip rate for a given condition • Calculate the doses for various drugs in pediatric population using appropriate formulae. • Calculate the doses for various drugs in special situations (renal/hepatic/heart diseases/obesity) using appropriate formulae. • Calculate the loading & maintenance doses.
  • 4. GENERAL METHODS FOR DRUG CALCULATION 1. BASIC FORMULA 2. RATIO& PROPORTION 3. FRACTIONAL EQUATION 4. BODY WEIGHT 5. BODY SURFACE AREA
  • 5. 1. Basic Formula • A=D/H X V • D-desired dose (drug dose ordered by health care provider) • H- on-hand (stock on hand/on label of container) • V- vehicle ( Q- quantity/drug form in which drug comes) • A- Amount calculated to be given to patient.
  • 6. Examples: • Avandia 2mg OD. How much tablet will you give? A=D/HXV • Solution: 2mg/4 x 1 tablet 4mg = .5 tablet
  • 7. Example • Paracetamol 500mg. Q 4 hour Round the Clock (RTC) p.o. The stock on hand is 250mg/5ml in 60ml bottle. How many ml should be administered? • D-500 mg, V- 5 ml,H-250mg • A=D/H X V A=500/250 X 5= 10 ml
  • 8. 2. Ratio and Proportion • H : V = D : X • Where: H = drug on hand (available) • V = vehicle/drug form (capsule/tablet/liquid) • D = desired dose (as ordered) • x = unknown amount to give
  • 9. Example • Order: Cefdinir (3rd gen cephalosporin) 100 mg PO q.i.d *How many mL should the patient receive? • H : V = D : X • 250:5=100:X • X=DV/H • X=100X5/250 • X=2 ML
  • 10. Fractional Equation • • Same as R & P except it is written as a fraction. • H/V = D/X • Example • Order:Ciprofloxacin 250 mg PO q12h*how many tablets should the client receive? • H/V = D/X • 750/1=250/X • 1/3 Tab
  • 11. 4. Body Weight (BW) • Allows individualization of the drug dose • Involves 3 steps: 1. Convert pounds to kg – 1 Kg = 2.2 lbs 2. 2. Determine drug dose per BW – Drug dose x body weight = patients dose per day 3. 3. Follow basic formula, R & P
  • 12. Example • Order: Fluorouracil (5-FU), 12 mg/kg/day IV, not to exceed 800 mg/day. The adult weighs 132 lb. • 1. Convert pounds to Kg : • 132/2.2 = 60kg • 2. mg x kg = patient’s dose: 12 x 60 = 720mg/day • Answer: fluorouracil 720 mg/day
  • 13. 5. Body Surface Area (BSA) Most accurate to calculate drug dose for: – Infants – Children – Older adults – patients who are on antineoplastic agents – low body weight BSA is expressed as square meters (m2). It can be determined using: - Equations (e.g., Mosteller Method, Du Bois Method) – Nomograms - An average-sized adult has a BSA of 1.73 m2
  • 16. nomogram • A nomogram has three columns: • - Height (expressed in centimeters and in inches) • - Body surface area (expressed in square meters) • - Weight (expressed in kilograms and in pounds) • - To use a nomogram, the height and weight of a patient are found on the nomogram and then a straight line is drawn connecting the two values. • - The BSA for that patient is found where the line intersects the BSA column.
  • 17. Example • Order:Cyclophosphamide (Cytoxan) 100 mg/m2/day, • IV; available dosage is 200mg; patient’s height is 70 inches, weight is 160 lbs. • 1. 70 inches and 160 lbs intersect the nomogram scale at 1.97 m2 (BSA). • 2. 100 mg x 1.97 = 197mgAnswer:Administer cyclophosphamide 197 mg/day
  • 20. IV Drip Rate Calculation: Drop factor of tubing: • Macrodrip = 10, 15, or 20 gtt/mL • Microdrip = 60 gtt/mL • The drop factor of the tubing is found on the tubing box. For calculations, it must be stated in the problem.
  • 21. Example A patient is to receive 1 L of Hartmann’s solution over the next 12 hours. What is the rate of infusion in drops per minute (dpm), if the drop factor is 60 drops per mL . Solution: Volume = 1 000 mL, since 1 L = 1 000 mL. Time = 12 hours. Drop Factor = 60 drops per mL. Substituting these values into the drip rate formula gives: Drip Rate (dpm) = 1 000ml/ 12 hr × 60 drops/ml/60 min/ h = 83.833 ≈ 84 drops/minutes .
  • 22. Drug dosing in special populations • A special population are persons displaying one or more of the following characteristics: • a. prone to under or over responding to usual dosing regimens • b. least able to tolerate, recognize, or communicate drug effects • c. accidentally frequently mis‐dose
  • 23. Patient conditions that may altered the dosing of most drugs • • Renal or hepatic disease,. • • Dialysis procedures • • Heart failure • • Obesity • • Age.
  • 24. Renal Disease Two important equatation are there for calculation of drug dose in renal disease patients Cockcroft-gault MDRD(eGFR) • The most common method of estimating glomerular filtration for the purpose of drug dosing is to measure /estimate Creatinine Clearance CrCl(ml/min)
  • 25. MDRD equation eGFR is estimated GFR calculated by the abbreviated MDRD equation : 186 x (Creatinine/88.4)-1.154 x (Age)-0.203 x (0.742 if female) x (1.210 if black).
  • 26.
  • 27. Modifying Doses for patients with renal impairment • It is possible to decrease the drug dose and retain the usual dosage interval, or • Retain the usual dose and increase the dosage interval, or • Both decrease the dosage and prolong the dosage interval • The choice was made depend on the route of drug administration, the dosage forms available
  • 28. St Stageg GFR* Description 1 90+ Normal kidney function but urine findings or structural abnormalities or genetic trait point to kidney disease 2 60-89 Mildly reduced kidney function, and other findings (as for stage 1) point to kidney disease 3A 3B 45-59 30-44 Moderately reduced kidney function 4 15-29 Severely reduced kidney function 5 <15 or on dialysis Very severe, or end-stage kidney failure
  • 29. For drugs with narrow therapeutic index • Measured or estimated CrCl may be used to estimate pharmacokinetic parameters for a patient based on prior studies conducted in other patients with renal dysfunction • Estimated pharmacokinetic parameters are then used in pharmacokinetic dosing equation to compute initial dose
  • 30. Hepatic Disorders • Most lipid soluble drugs are metabolized to some degree by the liver Two major types of liver disease 1. Hepatitis ‐ Acute hepatitis: mild, transient decreases in drug metabolism required no or minor changes in drug dosing ‐ Chronic hepatitis: irreversible hepatocytes damage required drug dosage changes. Patients with long term hepatocytes damage can progress to hepatic cirrhosis 2. Cirrhosis; a permanent lost of functional hepatocytes. Drug dosage schedules usually need to be modified
  • 31.
  • 32. Heart Failure • Is accompanied by a decrease in cardiac output results in lower liver and renal blood flow • Decreased drug bioavailability has been reported, due to collection of edema fluid in the GI tract difficult absorption and decreased blood flow to GI tract
  • 33. Obesity • Estimating the optimal dose for obese patients is difficult and, in many cases, ill defined. • Basing maintenance doses on total body weight is unlikely to result in a comparable drug response across different body sizes and generally increases the risk of adverse events. Individualised • dosing based on the patient’s lean body weight is recommended, with accompanying therapeutic drug monitoring and monitoring of the patient’s clinical response • .
  • 34. Body size descriptors commonly used in drug dosing Name Formula Total body weight (kg) – Ideal body weight (kg) 13 45.4 + 0.89 x (height (cm) – 152.4) + (4.5 if male) Adjusted body weight (kg) Correction factor* x (TBW – IBW) + IBW Lean body weight (kg) males 9270 x TBW (kg)6680+216 x BMI (kg/ m2) Females 9270 x TBW (kg)6680+244 x BMI (kg/ m2)
  • 35. Age Children are not small adults but rather distinct individuals who have different absorption, distribution, metabolism, and excretion rates of medications than adults.
  • 36. Pediatric considerations • Fried’s rule – • applies to the child younger than 1 year of age. • Infant dose= • infant age (months) X adult average dose/ 150
  • 37. Pediatric considerations • Young’s Rule- • applies to children 1-12 yr.
  • 38. Clark’s Rule • One of the most popular methods for determining medication dosages for children. • Based upon a child’s body weight and the assumption that the average normal adult weighs 150 pounds. • Ratio proportions are used in this method. • Clark’s rule should be used if no other formula is specified.
  • 39.
  • 40. Loading doses Loading doses are useful for drugs that are eliminated from the body relatively slowly • Such drugs need only a low maintenance dose in order to keep the amount of the drug in the body at the target level • Without loading, it would take longer for the amount of the drug to reach target level • Loading doses typically are adjusted based on Vd and are not adjusted for renal failure •If extracellular volume depletion is present, Vd may be reduced and reductions in loading dose should occur
  • 41. Three variables are used to calculate the loading dose: • Cp = desired peak concentration of drug • Vd = volume of distribution of drug in body • F = bioavailability •The required loading dose may then be calculated as: Loading dose = Cp x Vd x Ideal body weight/F •For an intravenously administered drug, the bioavailability F will equal 1, since the drug is directly introduced to the bloodstream. If the patient requires an oral dose, bioavailability will be less than 1 (depending upon absorption, first-pass metabolism, etc.), requiring a larger loading dose
  • 42. Drug Dosing–Maintenance Dose • Maintenance doses ensure steady-state blood concentrations and lessen the likelihood of sub-therapeutic regimens or overdoses •In the absence of a loading dose, maintenance doses will achieve 90% of their steady-state level in 3–4½ lives •Two options for ESRD • Reduce the dose • Lengthen the interval between doses (more useful for a drug with a wide therapeutic range and long half-life) • Maintenance dose can be calculated the same way as loading dose
  • 43. Conversions: • 1 liter (L) = 1000 ml (milliters) • 1 gram (g) = 1000 mgs (milligrams) • 1 mg (milligrams) = 1000 mcgs (micrograms) • 1 gram (g) = 15 grain (gr) • 1 grain (gr) = 60 mg (milligrams) • 1 dram (dr) =4 ml (milliters) • 1 ounce (oz) = 30 ml (milliters) • 1 tsp (teaspoon) = 5 ml (milliters) • 1 tbs (tablespoon) = 15 ml (milliters) • 1 kg (kilogram) = 2.2 lbs (pounds) • 1 inch = 2.54 cm (centimeters) • 16 ounces (ozs) = 1 lb (pound) • 1 cup = 8 ounces (ozs) 1 ml (milliter) = 15 minims • 1 tsp (teaspoon) = 5 ml (milliters) • 1 tbs (tablespoon) = 15 ml (milliters) • 1 drop (gtt) = 15 minims
  • 44. Q. The normal adult doses of medication is 150 mg you have a child that weighs 30 kg and is 1.2 meter in height. How much medication will you give to the child?
  • 45. Answer • Calculate BSA= 30kg x120cm/3600 =1 , now child dosage= BSA x ADULT DOSE / 1.7M2 = 88.24mg
  • 46. Q. A pediatric patient is to receive Atropine 0.02 mg/kg,the patient weight is 10 kg,what is the Desired Dose?
  • 47. • Desired Dose = .02mg/kg*10kg=.2mg Answer
  • 48. Q. Calculate the dose of Amoxicillin for 8 yr old girl using young’s formula ,when the adult dose of capsule Amoxicillin is 250 mg TDS ?
  • 49. • Youngs Formula = (Age/Age+12 )*Adult Dose so (8/8+12)*250 = 100mg Answer
  • 50. Q. Calculate the dose of Amoxicillin for 8 yr old girl using young’s formula ,when the adult dose of capsule Amoxicillin is 250 mg TDS ?
  • 51. • Youngs Formula = (Age/Age+12 )*Adult Dose so (8/8+12)*250 = 100mg Answer
  • 52. Q. Find out the dose of cephalexin using Dilling’s formula for a 2 yr old child when the adult dose is 500 mg TDS?
  • 53. • Dillings formula ={( Age / 20) *Adult Dose } , So 2/20 *500 = 50 mg Answer
  • 54. •Find out the dose of a drug X for a 3 yr old child by Dilling formula as well as young formula when adult dose of that drug is 650 mg TDS.
  • 55. • Dilling formula = Age/20 *Adult dose , So here Dose = 4/20*500mg=100mg Answer
  • 56. • Calculate the daily dose of Amikacin for 75 years old female obese patient weight 90 kg having S. creatinine – 2.5 mg/dl suffering from renal parenchyma disease.
  • 57. • Creatinine clearance in renal insufficiency = ( 140 - Age ) * Weight ( kg ) multipy 0.85 ( If females) /72 * S. Creatinine ( mg / ml ) • 140-75 *90*0.85*100/72*2.5 =2.763gm.